# DEVICE IDENTITY & INTENDED USE
**Document Version:** 1.0  
**Effective Date:** 2026-02-14  
**Regulatory Status:** LOCKED

---

## 1. DEVICE IDENTITY

### 1.1 Product Name
**Neurova Clinical Engine V1**

### 1.2 Device Type
**Software as a Medical Device (SaMD)**

### 1.3 Device Classification
- **Category:** Mental Health Screening Software
- **Regulatory Framework:** SaMD (Software as a Medical Device)
- **Risk Classification:** To be determined by regulatory authority based on intended use

---

## 2. INTENDED USE

### 2.1 Intended Use Statement
The **Neurova Clinical Engine V1** is a Software as a Medical Device (SaMD) designed to provide **structured digital screening** using **validated psychometric instruments** for mental health assessment purposes. The system facilitates the administration, scoring, and reporting of standardized mental health screening tools within licensed healthcare facilities.

### 2.2 Intended Users
**Licensed healthcare facilities with mental health professionals**, including but not limited to:
- Psychiatrists
- Clinical Psychologists
- Licensed Clinical Social Workers
- Psychiatric Nurse Practitioners
- Mental Health Counselors
- Other licensed mental health professionals operating within their scope of practice

### 2.3 Intended Patient Population
Adults (18 years and older) undergoing mental health screening in clinical settings.

### 2.4 Clinical Setting
- Licensed healthcare facilities
- Mental health clinics
- Hospital psychiatric departments
- Outpatient mental health centers
- Telehealth mental health services (when supervised by licensed professionals)

---

## 3. INDICATIONS FOR USE

The Neurova Clinical Engine V1 is indicated for:
- Administration of validated psychometric screening instruments
- Automated scoring of standardized mental health assessments
- Generation of structured screening summaries for clinical review
- Supporting clinical workflow in mental health screening processes

---

## 4. EXPLICIT EXCLUSIONS

### 4.1 What This Device Does NOT Do

> [!CAUTION]
> **The Neurova Clinical Engine V1 does NOT:**
> - **Diagnose** any mental health condition
> - **Treat** any mental health condition
> - **Prescribe** medications or therapeutic interventions
> - **Autonomously interpret** screening results
> - **Replace** clinical judgment or professional assessment
> - **Provide** medical advice or treatment recommendations
> - **Make** clinical decisions independently

### 4.2 Not Intended For
- Standalone diagnostic use without professional oversight
- Emergency mental health crisis intervention
- Suicide risk assessment as a sole tool
- Use by unlicensed individuals for clinical decision-making
- Direct-to-consumer mental health diagnosis
- Automated treatment planning

---

## 5. CONTRAINDICATIONS & LIMITATIONS

### 5.1 Contraindications
- Use in emergency psychiatric situations requiring immediate intervention
- Use as the sole basis for diagnosis or treatment decisions
- Use by individuals without appropriate clinical licensure

### 5.2 Limitations
- Screening results must be interpreted by qualified mental health professionals
- Results are dependent on the accuracy of patient-provided information
- Not validated for pediatric populations (under 18 years)
- Requires professional clinical correlation with patient history and presentation

---

## 6. SYSTEM OUTPUT SPECIFICATIONS

### 6.1 Output Type
**Screening Summary** (NOT Diagnostic Report)

### 6.2 Output Content
All system outputs shall include:
- Standardized screening instrument scores
- Structured summary of responses
- Clear labeling as "Screening Summary"
- Mandatory intended use disclaimer (see Section 7)

### 6.3 Output Format
- PDF reports with embedded disclaimers
- Digital interface displays with header disclaimers
- All outputs clearly labeled as screening tools, not diagnostic instruments

---

## 7. MANDATORY DISCLAIMERS

### 7.1 Standard Intended Use Disclaimer
All PDF reports, UI interfaces, and system outputs **MUST** include the following disclaimer:

> **SCREENING SUMMARY – NOT A DIAGNOSIS**
> 
> This document contains screening results generated by the Neurova Clinical Engine V1, a Software as a Medical Device (SaMD) designed for structured digital screening using validated psychometric instruments.
> 
> **This system does NOT diagnose, treat, prescribe, or autonomously interpret mental health conditions.**
> 
> All screening results must be reviewed and interpreted by a licensed mental health professional within the context of comprehensive clinical assessment. This screening summary is intended to support, not replace, clinical judgment.
> 
> **For use only by licensed healthcare facilities with qualified mental health professionals.**

### 7.2 UI Header Requirement
All user interface screens displaying screening results **MUST** include a prominent header:

```
SCREENING SUMMARY
This is a screening tool. Results require professional clinical interpretation.
```

### 7.3 Consistency Requirement
The intended use disclaimer must be **identical** across:
- All PDF reports
- All UI screens
- All exported data
- All system documentation provided to users

---

## 8. REGULATORY COMPLIANCE REQUIREMENTS

### 8.1 Documentation Requirements
This intended use statement must be:
- Included in all regulatory submissions
- Referenced in all marketing materials
- Displayed in user-facing documentation
- Maintained in version control with change tracking

### 8.2 Prohibited Language
The following terms are **PROHIBITED** in all system outputs, UI elements, and documentation:
- "Diagnosis" or "Diagnose" (except in disclaimers stating what the system does NOT do)
- "Treatment" or "Treat" (except in exclusion statements)
- "Prescribe" or "Prescription"
- "Medical decision"
- "Clinical decision" (when implying autonomous system decisions)
- Any language suggesting autonomous clinical interpretation

### 8.3 Permitted Language
The following terms are **APPROVED** for use:
- "Screening"
- "Screening Summary"
- "Assessment Results" (when clearly labeled as screening)
- "Psychometric Instrument"
- "Standardized Screening Tool"
- "Clinical Support Tool"
- "For Professional Review"

---

## 9. VERSION CONTROL

**Document Version:** 1.0  
**Device Version:** Neurova Clinical Engine V1  
**Status:** LOCKED  
**Last Review Date:** 2026-02-14  
**Next Review Date:** 2027-02-14 (or upon any material change to device functionality)

### 9.1 Change Control
Any modifications to this intended use statement require:
- Regulatory review
- Impact assessment on device classification
- Update to all system components referencing intended use
- Version increment and documentation

---

## 10. SYSTEM IMPLEMENTATION REQUIREMENTS

### 10.1 PDF Generation Requirements
✅ **MUST IMPLEMENT:**
- Identical intended use disclaimer on every PDF report
- "Screening Summary" as document title
- No diagnostic language in any PDF content
- Disclaimer placement: First page, prominently displayed

### 10.2 User Interface Requirements
✅ **MUST IMPLEMENT:**
- Header label: "Screening Summary" on all result screens
- Persistent disclaimer visible when viewing results
- No diagnostic terminology in UI labels or buttons
- Clear indication that professional review is required

### 10.3 Data Export Requirements
✅ **MUST IMPLEMENT:**
- Intended use disclaimer in all exported data formats
- Metadata indicating "screening" classification
- No diagnostic claims in export file names or headers

---

## 11. VALIDATION & VERIFICATION

### 11.1 Verification Checklist
- [ ] All PDFs contain identical intended use disclaimer
- [ ] UI headers display "Screening Summary" label
- [ ] No prohibited diagnostic language exists in codebase
- [ ] All user-facing text reviewed for compliance
- [ ] Export formats include required disclaimers

### 11.2 Ongoing Compliance
- Regular audits of UI text and output formats
- Code review requirements for any patient-facing content changes
- Automated testing for disclaimer presence in all outputs

---

## 12. REGULATORY RATIONALE

### 12.1 Why This Document Exists
Regulatory authorities classify medical devices based on their **Intended Use**. Vague or inconsistent intended use statements increase classification risk and may result in:
- Delayed regulatory approval
- Requirement for higher-risk classification
- Additional clinical validation requirements
- Market access restrictions

### 12.2 Classification Impact
By clearly defining this device as a **screening tool** that does NOT diagnose, treat, or prescribe, we:
- Establish appropriate risk classification
- Clarify regulatory pathway
- Set clear boundaries for clinical use
- Reduce liability exposure
- Ensure appropriate professional oversight

---

## DOCUMENT APPROVAL

**Prepared By:** Regulatory Affairs  
**Reviewed By:** [To be completed]  
**Approved By:** [To be completed]  
**Effective Date:** 2026-02-14

---

**END OF DOCUMENT**
